ONCY - Oncolytics Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCY is currently covered by 2 analysts with an average price target of $3.97. This is a potential upside of $3.16 (390.12%) from yesterday's end of day stock price of $0.81.

Oncolytics Biotech's activity chart (see below) currently has 3 price targets and 13 ratings on display. The stock rating distribution of ONCY is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for ONCY is $5, Lowest price target is $5, average price target is $3.97.

Most recent stock forecast was given by PATRICK TRUCCHIO from HC WAINWRIGHT on 19-Sep-2024. First documented stock forecast 17-Feb-2021.

Best performing analysts who are covering ONCY - Oncolytics Biotech:

John Newman Patrick Trucchio

Currently out of the existing stock ratings of ONCY, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$5

$3.93 (367.29%)

$5

4 months 5 days ago
(19-Sep-2024)

0/8 (0%)

$4.05 (426.32%)

Buy

$5

$3.93 (367.29%)

$5

1 years 7 months 1 days ago
(23-Jun-2023)

0/3 (0%)

$2.26 (82.48%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCY (Oncolytics Biotech) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on ONCY (Oncolytics Biotech) with a proven track record?

JOHN NEWMAN

Which analyst has the current lower performing score on ONCY (Oncolytics Biotech) with a proven track record?

PATRICK TRUCCHIO

Which analyst has the most public recommendations on ONCY (Oncolytics Biotech)?

John Newman works at CANACCORD and has 5 price targets and 4 ratings on ONCY

Which analyst is the currently most bullish on ONCY (Oncolytics Biotech)?

Patrick Trucchio with highest potential upside - $3.93

Which analyst is the currently most reserved on ONCY (Oncolytics Biotech)?

John Newman with lowest potential downside - $3.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?